FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.67B
AUM Growth
+$293M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1
+$29.1M
2
+$24.4M
3
+$18.2M
4
ORIC icon
Oric Pharmaceuticals
ORIC
+$16.6M
5
BBIO icon
BridgeBio Pharma
BBIO
+$14.1M

Top Sells

1
+$11.6M
2
+$11.6M
3
+$7.79M
4
RNA icon
Avidity Biosciences
RNA
+$7.67M
5
REPL icon
Replimune Group
REPL
+$6.97M

Sector Composition

1 Healthcare 99.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$17M 1.01%
830,983
27
$16.6M 0.99%
+2,142,855
28
$16.4M 0.98%
6,881,090
+217,500
29
$15.2M 0.91%
265,511
+51,271
30
$12.5M 0.75%
393,000
31
$10.2M 0.61%
+100,430
32
$9.65M 0.58%
1,803,204
+100,000
33
$8.98M 0.54%
386,762
-300,000
34
$8.92M 0.53%
3,746,857
35
$8.73M 0.52%
127,900
36
$8.31M 0.5%
203,684
37
$7.08M 0.42%
285,331
38
$5.8M 0.35%
749,022
+66,561
39
$5.69M 0.34%
300,000
-285,759
40
$5.63M 0.34%
85,495
+13,457
41
$5.21M 0.31%
+370,000
42
$4.85M 0.29%
881,173
43
$4.68M 0.28%
2,401,714
-2,760,634
44
$3.63M 0.22%
780,000
-996,479
45
$3.54M 0.21%
1,647,030
46
$2.74M 0.16%
264,377
47
$1.74M 0.1%
92,500
-95,346
48
$1.05M 0.06%
500,333
49
– –
-1,112,684
50
– –
-500,000
1
2
3